Youngjoo Lee

机构：Kangbuk Samsung Hospital, National Cancer Center · ORCID：0000-0003-0180-189X

发表论文 154 篇 · 总被引 1528 次 · h-index 20

代表论文

• Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation–Positive Non–Small Cell Lung Cancer (BLOSSOM) (2024 · Journal of Clinical Oncology · 被引 56)
• Tiktag: Breaking ARM's Memory Tagging Extension with Speculative Execution (2025 · 被引 11)
• Molecular subtype changes after acquiring resistance to tarlatamab in small cell lung cancer (2024 · Drug Resistance Updates · 被引 11)
• Fibroblast TGF-β signaling defines spatial tumor ecosystems linked to immune checkpoint blockade resistance (2025 · Communications Biology · 被引 10)
• Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer (2024 · International Journal of Molecular Sciences · 被引 6)
• Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 被引 4)